logo
State leaders give Connecticut schools easier access to grants for HVAC improvements

State leaders give Connecticut schools easier access to grants for HVAC improvements

Yahooa day ago

BRISTOL, Conn. (WTNH) — A pandemic-era program intended to help schools address concerns about indoor air quality will live on as a permanent feature of the state's wide-ranging school construction funding system.
Efforts to improve indoor air quality in schools has been a longstanding priority for local leaders, with many noting the negative effects of aging ventilation systems servicing school buildings constructed in the mid or late 20th century.
Can AI help solve Hartford's pothole problem?
A lack of sufficient air conditioning means schools are often forced to close due to extreme heat. Worn-down ventilation systems can be ineffective when it comes to removing dust particles that carry disease and agitate the lungs of asthmatic students.
The pandemic put those shortcomings centerstage, and state leaders rushed to act. Starting in 2022, the state government doled out $178 million in grants to help schools upgrade or replace their heating, ventilation, and air conditioning (HVAC) systems, with 163 schools receiving funds.
Though the height of the pandemic is now in the rearview window, leaders still hoped to address the longer-term issue of air quality and climate control that still poses challenges for schools across the state. The response to those calls for improvements came in the form of a policy change that state leaders framed as a more permanent, consistent fix.
Rather than distributing funds through ad hoc grant programs, cash for school HVAC upgrades will now be included as part of the state's school construction funding system. The HVAC grants under the school construction program will be easy to apply for, Commissioner Michelle Gilman, the official who oversees the program, said.
'It's a monthly application,' Gilman explained. 'It's not a competitive grant program. So, again we have made this very easy for our school districts to demonstrate the need and apply for that.'
Gilman and Lt. Gov. Susan Bysiewicz (D) visited a school in Bristol which received money as part of the earlier grants to tout the new funding arrangement.
'We've eliminated having to cancel school because of extremely hot days,' Peter Fusco, Bristol Public Schools Director of Facilities, said of the system that has been installed in South Side School.
Bysiewicz applauded the work done in Bristol and the coming funds for other districts. She noted the dual utility of the new systems — taming the effects of extreme temperatures while not losing focus of one of the original forces that drove the state spending.
'The public health benefits are really strong as well,' Bysiewicz said.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RBC Capital Lifts Gilead Sciences (GILD) PT to $95 On Insights From a 2022 Patient Survey
RBC Capital Lifts Gilead Sciences (GILD) PT to $95 On Insights From a 2022 Patient Survey

Yahoo

time17 minutes ago

  • Yahoo

RBC Capital Lifts Gilead Sciences (GILD) PT to $95 On Insights From a 2022 Patient Survey

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 11 most profitable NASDAQ stocks to buy now. On June 11, RBC Capital increased its price target for Gilead Sciences to $95 from $92, while maintaining a Sector Perform rating. This adjustment is based on insights from a 2022 patient survey, which assessed perceptions of lenacapavir among high-risk individuals on and off PrEP (pre-exposure prophylaxis), especially after phase 3 data release and in anticipation of its potential market launch. The firm's analysis suggests that high clinician engagement, lower-than-expected adherence to oral PrEP medications, and the potential for current PrEP users to switch to lenacapavir could all facilitate growth for Gilead Sciences, even with some cannibalization of its existing product called Descovy. A physician and a patient having a discussion in a hospital about biopharmaceutical medicines. In Q1 2025, Gilead Sciences reported total revenue of $6.67 billion, which was flat year-on-year and missed Street's estimates by 2.1%. Despite the revenue miss, Gilead reconfirmed its full-year revenue guidance at the midpoint of $28.4 billion, which is 1.1% below analysts' estimates. These results were driven by growth in the company's core HIV and liver disease segments, particularly from strong demand for Biktarvy and the ongoing launch of Libdelzi. Gilead Sciences Inc. (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need in the US, Europe, and internationally. While we acknowledge the potential of GILD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.

Entrepreneur UK's London 100: Zonder Health Ltd
Entrepreneur UK's London 100: Zonder Health Ltd

Entrepreneur

time10 hours ago

  • Entrepreneur

Entrepreneur UK's London 100: Zonder Health Ltd

Zonder leverages AI to lighten provider workloads and deliver top-tier, cost-effective care Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media. Industry: Healthcare Last, but certainly not least, on the Entrepreneur UK London100 list is Zonder. Founded in 2024, Zonder leverages AI to lighten provider workloads and deliver top-tier, cost-effective care. With over a quarter of the UK population managing chronic conditions — accounting for half of all GP appointments and three-quarters of health spending — the demand on healthcare is immense. Amid a shortage of qualified professionals, Zonder steps in to manage these chronic conditions, easing the burden on primary care providers. By combining AI with a patient-centered approach, Zonder is revolutionising chronic disease management. Its innovative model integrates AI with human expertise, offering a scalable solution that improves patient outcomes while optimizing healthcare resources. The company stands as a beacon of innovation in healthcare, embodying the entrepreneurial spirit that drives progress in the city. Zonder's AI platform streamlines admin enhances patient communication, and meets QoF targets, freeing up providers to focus on delivering care.

ChatGPT Is Telling People With Psychiatric Problems to Go Off Their Meds
ChatGPT Is Telling People With Psychiatric Problems to Go Off Their Meds

Yahoo

timea day ago

  • Yahoo

ChatGPT Is Telling People With Psychiatric Problems to Go Off Their Meds

This week, my colleague Maggie Harrison Dupré published a blockbuster story about how people around the world have been watching in horror as their family and loved ones have become obsessed with ChatGPT and started suffering severe delusions. The entire piece is filled with disturbing examples of the OpenAI chatbot feeding into vulnerable folks' mental health crises, often by affirming and elaborating on delusional thoughts about paranoid conspiracies and nonsensical ideas about how the user has unlocked a powerful entity from the AI. One particularly alarming anecdote, due to its potential for harm in the real world: a woman who said her sister had managed her schizophrenia with medication for years — until she became hooked on ChatGPT, which told her the diagnosis was wrong, prompting her to stop the treatment that had been helping hold the condition at bay. "Recently she's been behaving strange, and now she's announced that ChatGPT is her 'best friend' and that it confirms with her that she doesn't have schizophrenia," the woman said of her sister. "She's stopped her meds and is sending 'therapy-speak' aggressive messages to my mother that have been clearly written with AI." "She also uses it to reaffirm all the harmful effects her meds create, even if they're side effects she wasn't experiencing," she added. "It's like an even darker version of when people go mad living on WebMD." That outcome, according to Columbia University psychiatrist and researcher Ragy Girgis, represents the "greatest danger" he can imagine the tech posing to someone who lives with mental illness. When we reached out to OpenAI, it provided a noncommittal statement. "ChatGPT is designed as a general-purpose tool to be factual, neutral, and safety-minded," it read. "We know people use ChatGPT in a wide range of contexts, including deeply personal moments, and we take that responsibility seriously. We've built in safeguards to reduce the chance it reinforces harmful ideas, and continue working to better recognize and respond to sensitive situations." Do you know of anyone who's been having mental health problems since talking to an AI chatbot? Send us a tip: tips@ -- we can keep you anonymous. We also heard other stories about people going off medication for schizophrenia and bipolar disorder because AI told them to, and the New York Times reported in a followup story that the bot had instructed a man to go off his anxiety and sleeping pills; it's likely that many more similarly tragic and dangerous stories are unfolding as we speak. Using chatbots as a therapist or confidante is increasingly commonplace, and it seems to be causing many users to spiral as they use the AI to validate unhealthy thought patterns, or come to attribute disordered beliefs to the tech itself. As the woman's sister pointed out, it's striking that people struggling with psychosis are embracing a technology like AI in the first place, since historically many delusions have centered on technology. "Traditionally, [schizophrenics] are especially afraid of and don't trust technology," she told Futurism. "Last time in psychosis, my sister threw her iPhone into the Puget Sound because she thought it was spying on her." Maggie Harrison Dupré contributed reporting. More on AI and mental health: Therapy Chatbot Tells Recovering Addict to Have a Little Meth as a Treat

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store